Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-01-28 @ 10:50 PM
Study NCT ID:
NCT05884320
Status:
RECRUITING
Last Update Posted:
2025-10-09
First Post:
2023-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
Sponsor:
Organization: